D. Fraidenburg

发表

Pathogenic Mechanisms of Pulmonary Hypertension

D. Fraidenburg, J. Yuan, 2015 .

Deficiency of Akt1, but not Akt2, attenuates the development of pulmonary hypertension.

J. Garcia, R. Machado, M. Bonini, 2015, American journal of physiology. Lung cellular and molecular physiology.

Unsupervised Clustering Reveals Sarcoidosis Phenotypes Marked by a Reduction in Lymphocytes Relate to Increased Inflammatory Activity on 18FDG-PET/CT

D. Fraidenburg, Yang Lu, R. Baughman, 2021, Frontiers in Medicine.

Angiotensin-(1-7) in Paraventricular Nucleus Contributes to the Enhanced Cardiac Sympathetic Afferent Reflex and Sympathetic Activity in Chronic Heart Failure Rats

Feng Zhang, D. Fraidenburg, Haiyang Tang, 2017, Cellular Physiology and Biochemistry.

Advances in the Management of Pulmonary Arterial Hypertension

D. Fraidenburg, J. Yuan, Kimberly A. Smith, 2013 .

A Pilot Study of End-Tidal Carbon Dioxide in Prediction of Inhospital Cardiac Arrests

D. Fraidenburg, Scott T. Benken, J. Mucksavage, 2020, Critical care explorations.

Notch Activation of Ca(2+) Signaling in the Development of Hypoxic Pulmonary Vasoconstriction and Pulmonary Hypertension.

K. Ocorr, R. Bodmer, P. Thistlethwaite, 2015, American journal of respiratory cell and molecular biology.

Benzodiazepine misadventure in acute alcohol withdrawal: the transition from delirium tremens to ICU delirium

D. Fraidenburg, S. Kane, Michael T. Johnson, 2013, Journal of Anesthesia.

Upregulated Copper Transporters in Hypoxia-Induced Pulmonary Hypertension

R. Machado, D. Fraidenburg, J. Yuan, 2014, PloS one.

Hemin-Induced Endothelial Dysfunction and Endothelial to Mesenchymal Transition in the Pathogenesis of Pulmonary Hypertension Due to Chronic Hemolysis

D. Fraidenburg, Janae Gonzales, K. Holbert, 2022, International journal of molecular sciences.

A Review of Transcriptome Analysis in Pulmonary Vascular Diseases.

R. Machado, D. Fraidenburg, 2018, Methods in molecular biology.

Targeted therapies: endothelin receptor antagonists

D. Fraidenburg, J. Yuan, Kimberly A. Smith, 2013 .

Hungry for more: autophagy in the pathogenesis of pulmonary arterial hypertension.

D. Fraidenburg, J. Yuan, 2013, Circulation research.

G enetic alterations in pulmonary arterial hypertension Hungry for More Autophagy in the Pathogenesis of Pulmonary Arterial Hypertension

D. Fraidenburg, J. Yuan, 2013 .

Non-Muscle MLCK Contributes to Endothelial Cell Hyper-Proliferation through the ERK Pathway as a Mechanism for Vascular Remodeling in Pulmonary Hypertension

D. Fraidenburg, Y. Epshtein, J. Jacobson, 2022, International journal of molecular sciences.

smooth muscle cells endothelin-A receptor expression in lung artery Fibroblast growth factor mediates hypoxia-induced

S. Oparil, S. Wedgwood, M. Bonini, 2015 .

Pathogenic Mechanisms of Pulmonary Arterial Hypertension

D. Fraidenburg, J. Yuan, Haiyang Tang, 2022, JACC. Asia.

Bosentan as Rescue Treatment in Refractory Hypoxemia and Pulmonary Hypertension in a Patient with ARDS and H7N9 Influenza Virus Infection

D. Fraidenburg, Jian-An Huang, Q. Guo, 2014, Lung.

MicroRNA-212-5p, an anti-proliferative miRNA, attenuates hypoxia and sugen/hypoxia-induced pulmonary hypertension in rodents

M. Maienschein-Cline, D. Fraidenburg, K. Obrietan, 2022, Molecular therapy. Nucleic acids.

Red blood cell exchange to avoid intubating a COVID‐19 positive patient with sickle cell disease?

D. Fraidenburg, S. Campbell-Lee, Jason Crane, 2020, Journal of clinical apheresis.

Pulmonary hypertension associated with thalassemia syndromes

D. Fraidenburg, R. Machado, 2016, Annals of the New York Academy of Sciences.

Pulmonary Vascular Anatomy

D. Fraidenburg, J. Yuan, A. Rizzo, 2014 .

Inhaled Antibiotics for Gram-Negative Respiratory Infections

D. Fraidenburg, L. Danziger, E. Wenzler, 2016, Clinical Microbiology Reviews.

Pathogenic role of calcium-sensing receptors in the development and progression of pulmonary hypertension.

T. Zhou, D. Fraidenburg, J. Yuan, 2016, American journal of physiology. Lung cellular and molecular physiology.

Current and future therapeutic targets for pulmonary arterial hypertension.

D. Fraidenburg, J. Yuan, 2013, High altitude medicine & biology.

Diagnosis and Treatment of Pulmonary Arterial Hypertension

D. Fraidenburg, J. Yuan, S. Gaine, 2014 .

Thrombin‐mediated activation of Akt signaling contributes to pulmonary vascular remodeling in pulmonary hypertension

I. Yamadori, D. Fraidenburg, A. Ogawa, 2013, Physiological reports.

Foreword: Current therapies for the treatment of pulmonary arterial hypertension

D. Fraidenburg, J. Yuan, Kimberly A. Smith, 2013 .

Delivery of fetus death with misoprostol in a pregnant woman with H7N9 avian influenza A virus pneumonia and ARDS

D. Fraidenburg, Daguo Zhao, Shenlang Liu, 2014, Critical Care.

Pulmonary Vascular Physiology and Pathophysiology

D. Fraidenburg, J. Yuan, A. Rizzo, 2014 .

Pharmacology and Emerging Therapies for Group 3 Pulmonary Hypertension Due to Chronic Lung Disease

D. Fraidenburg, J. Gonzales, 2023, Pharmaceuticals.

Expression profile of mitochondrial voltage-dependent anion channel-1 (VDAC1) influenced genes is associated with pulmonary hypertension

Jae-Hong Ko, D. Fraidenburg, Jeongyoon Choi, 2017, The Korean journal of physiology & pharmacology : official journal of the Korean Physiological Society and the Korean Society of Pharmacology.

Editorial: Perspectives in pharmacological therapy targeting cellular metabolic pathways in respiratory diseases

D. Fraidenburg, Peiran Yang, Na Wang, 2023, Frontiers in pharmacology.